Can you provide the average price target for HELMERICH & PAYNE stock?
25 analysts have analysed HP and the average price target is 37.89 USD. This implies a price increase of 1.79% is expected in the next year compared to the current price of 37.22.
NYSE:HP • US4234521015
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HELMERICH & PAYNE (HP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-15 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2026-04-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-04-07 | Susquehanna | Maintains | Positive -> Positive |
| 2026-02-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-10 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-09 | TD Cowen | Maintains | Hold -> Hold |
| 2026-02-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-01-07 | TD Cowen | Maintains | Hold -> Hold |
| 2026-01-07 | Susquehanna | Maintains | Positive -> Positive |
| 2025-12-18 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-10 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-11-25 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-11-25 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-21 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-11-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-19 | Susquehanna | Maintains | Positive -> Positive |
| 2025-11-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-10-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-06 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-22 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-08-19 | TD Cowen | Maintains | Hold -> Hold |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.872B 39.51% | 2.757B -4.03% | 3.746B 35.89% | 4.102B 9.50% | 4.239B 3.34% | 4.329B 2.12% | 4.071B -5.96% | 4.062B -0.22% | 3.418B -15.85% | |
| EBITDA YoY % growth | 925.843M 114.67% | 848.055M -8.40% | 860.309M 1.44% | 890.75M 3.54% | 951.1M 6.78% | 1.003B 5.46% | 959.96M -4.29% | 941.42M -1.93% | 1.003B 6.54% | |
| EBIT YoY % growth | 543.529M 1,833.03% | 450.711M -17.08% | 235.224M -47.81% | 159.28M -32.29% | 261.26M 64.03% | 343.67M 31.54% | 208.06M -39.46% | 198.79M -4.46% | 636.54M 220.21% | |
| Operating Margin | 18.92% | 16.35% | 6.28% | 3.88% | 6.16% | 7.94% | 5.11% | 4.89% | 18.62% | |
| EPS YoY % growth | 4.15 4,050.00% | 3.49 -15.90% | 0.96 -72.64% | 0.25 -74.12% | 1.06 328.43% | 1.84 73.83% | 1.12 -39.02% | 0.98 -12.84% | 5.11 422.11% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | Q1 / 29 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -143.05% | 0.13 -42.48% | 0.20 2,112.41% | 0.25 267.84% | 0.26 1,857.83% | 0.34 171.04% | 0.40 99.10% | 0.26 4.32% | 0.24 -10.18% | 0.25 -26.13% | 0.29 -26.74% | 0.29 9.80% |
| Revenue Q2Q % growth | 979.05M -3.64% | 1.021B 0.12% | 1.053B 4.08% | 1.053B 3.54% | 1.028B 5.00% | 1.055B 3.33% | 1.069B 1.52% | 1.008B -4.27% | 999.05M -2.82% | 1.004B -4.83% | 1.018B -4.77% | 1.021B 1.29% |
| EBITDA Q2Q % growth | 197.47M -38.47% | 220.72M -54.88% | 238.39M -63.25% | 239.08M 5.79% | 238.59M 20.82% | 249.2M 12.90% | 254.8M 6.88% | 236.77M -0.97% | 233.52M -2.12% | 235.74M -5.40% | 241.28M -5.31% | 240.69M 1.66% |
| EBIT Q2Q % growth | 13.506M -78.97% | 41.1M -22.40% | 60.665M 156.52% | 68.745M 55.97% | 71.07M 426.21% | 74.16M 80.44% | 73.13M 20.55% | N/A | N/A | N/A | N/A | N/A |
All data in USD
25 analysts have analysed HP and the average price target is 37.89 USD. This implies a price increase of 1.79% is expected in the next year compared to the current price of 37.22.
HELMERICH & PAYNE (HP) will report earnings on 2026-05-06, after the market close.
The consensus EPS estimate for the next earnings of HELMERICH & PAYNE (HP) is -0.02 USD and the consensus revenue estimate is 979.05M USD.
The number of analysts covering HELMERICH & PAYNE (HP) is 25.